. The unadsorbed fraction and the adsorbed material eluted with 0-1N-HCI were lyophilized to yield white powders. The hypothalamic material insoluble in acetic acid was extracted with hot aq. 0-5% acetic acid. Bioasway Adrenocorticotrophic hormone. The in vitro bioassay of Saffran & Schally (1955b) was used for the estimation of ACTH in the tissue preparations and in the CRF test outlined below.
Corticotrophin-releasing factor. The detection of CRF activity was carried out by the method of Schally & Saffran (1956) , which is a modification of the original method of Saffran & Schally (1955a) . Anterior-pituitary tissue of the rat was cut into halves, one of which served as the control tissue to obtain the 'unstimulated' release of ACTH, and the other half was incubated for 1 hr. in the presence of the sample to be tested. A positive test for CRF was denoted by a significantly greater release of ACTH from the test tissue, indicated by a lower fiducial limit greater than 1. The potency of the CRF preparations was estimated from the lowest dose that caused a significant stimulation of the release of ACTH. In the earlier tests, 0-2 mM-( -)-noradrenaline was added to keep conditions the same as in the original method (Saffran & Schally, 1955a) . Arterenol is, however, not required to demonstrate CRF activity in tissue extracts. In more recent tests, the pituitary tissue was pre-incubated for 1 hr. before the addition of CRF to the test tissue. The pre-incubation medium was discarded (cf. Saffran & Bayliss, 1953) . Preincubation decreased and made more consistent the release of ACTH by the control tissue. In all cases the material under test was added to the experimental tissue at the start of the incubation period and to the control tissue at the end of the incubation period. In this way, all the adrenal tissue in the assay for ACTH was exposed to the materials added with the test sample. This Elution. Selected zones were cut horizontally from the chromatograms and were eluted by descending chromatography with 0.5% acetic acid for 8-20 hr., depending upon the area of the paper. The eluates, in 100 ml. beakers, were concentrated to small volumes or to dryness in vacuo over NaOH.
Amino acid analysis. The amino acids were determined as described by Peart (1956) , except that the two-dimensional chromatographic method of Levy & Chung (1953) was used to separate the amino acids. The Reduction. Reduction with thioglycollate was carried out according to Ames, Moore & Van Dyke (1950) , except that the concentration of thioglycollic acid was increased to 0-05M and the time of reaction to 24 hr.
Oxidation. Performic acid oxidation was carried out by the method of Sanger (1949) or Popenoe & du Vigneaud (1953) . This procedure destroys the pressor and ACTH activities (Dedman, Farmer & Morris, 1955) .
RESULTS

Activity of neural-tissue extract8
Several preparations of neural origin were explored for CRF activity in the search for a suitable starting material for the concentration of CRF. Of the preparations examined (Table 1) , hypothalamic extracts and Protopituitrin exhibited consistent activity at a dose of 10 ,ug. Protopituitrin was chosen for further study because it is available in relatively large amounts as a stage in the preparation of vasopressin and oxytocin. The apparent inhibition of release of ACTH by higher doses of some preparations is partly explained by the presence of ACTH in these preparations. The addition of external ACTH to the test system masks the stimulated release of ACTH by the isolated pituitary tissue. Table 2 lists the ACTH content of two posterior-lobe preparations and shows how treatment of Protopituitrin with oxycellulose decreases markedly the contamination by ACTH.
Earlier experiments (Saffran et al. 1955 ) had suggested that CRF had the properties of a peptide. Accordingly paper-chromatographic methods used for the separation of peptides were applied to the concentration of CRF from Protopituitrin. Protopituitrin separated into a largenumber ofninhydrinstaining components in each of the solvent systems, and the zone containing CRF activity in each system was located by testing eluates of portions of the paper. Both ninhydrin and biologicalactivity patterns were reproducible. The systems were then applied serially to concentrate the CRF. Stage8 of purification (1) Chromatography in butanol-acetic acid-water.
The CRF activity was recovered in the zone with Rp 0-05-0-2 (lysine=0-18). This zone contained one-half to one-quarter of the weight of the Protopituitrin applied to the starting line, so that the active material eluted from this zone was concentrated two to four times.
(2) Chromatography in m-cre8ol. The active material from step 1 was chromatographed in the m-cresol system. After development, the paper was dried overnight in the fume hood at room temperature, with an extra fan to increase the circulation of air within the hood. The area with R. 0-46-0-64 consistently contained the activity. Eluates of this zone were taken to dryness several times in vacuo over NaOH to remove traces of m-cresol. The material contained one-twenty-fifth to onefortieth of the weight of Protopituitrin.
(3) Rechromatography in m-cresol. The eluate from step 2 was rechromatographed on washed filter paper in the m-cresol system to separate completely from CRF the faster-running peptides, including vasopressin (R. 0-85), which tended to tail at the relatively high loads used in step 2, and thus contaminate the CRF. The zone with R1 0-46-0-64 again contained the activity in about l l of the starting weight of Protopituitrin. Washed paper was used in this and in the subsequent two steps to minimize contamination of the preparation with substances such as metals which might hasten inactivation.
(4) Chronatography in acetone-water. The material concentrated in step 3 was chromatographed in the actone-water system, in which the activity was weight of Protopituitrin, as estimated by the method of Lowry et al. (1951) . The other active zone contained even less material.
The steps in the purification of CRF are outlined in Table 3 . At each step, a portion corresponding to 10 jig. of Protopituitrin was used in the biological test for CRF (Table 4) . This dose is consistently active, suggesting that there were no serious losses in activity during the course of purification. In contrast, similar doses of material eluted from other zones in the first four steps were inactive.
The facilities of our Laboratory limited the capacity of each run to 3 g. of Protopituitrin. Table 3 illustrates the enormous amount of labour involved in the spotting, running and elution of approximately 50 chromatograms needed to concentrate 600 ,ug. of CRF. Table 5 lists the R. of CRF, the vasopressins, oxytocin and a-corticotrophin in the four solvent systems to demonstrate the ability of the combination of these systems to separate CRF from the other known hormones in the starting material.
Amino acid composition (Table 7) . However, treatment with 2-2N-HCI at 1100 for 90 min. does not apparently affect the activity of a CRF preparation at the third step of the purification procedure. DISCUSSION At present, the greatest weight of evidence supports the hypothesis that the release of ACTH from the adenohypophysis is governed by a material elaborated in the hypothalamic area of the brain (Harris, 1951) . Proof of this hypothesis requires the isolation of material, from the hypothalamus, which activates the release of ACTH from the pituitary in a system in which the response to stress has been abolished by some means. The existence of a special, short vascular route (the hypophysial-portal system) for this material suggests that its biological activity is relatively short-lived. The anatomical relationship between the hypothalamus and the neurohypophysis further implies that the substance may be found in the posterior lobe of the pituitary body as well (Zuckerman, 1952) , in a manner analogous to the hormones of the posterior lobe, oxytocin and vasopressin (Scharrer & Scharrer, 1954) . As a rule, the hormones elaborated by any one endocrine organ are members of the same chemical family. If the hypothalamus-neurohypophysis system obeys this rule, then the hypothetical substance suggested by Harris (1951) and others should be chemically similar to the peptide hormones, vasopressin and oxytocin. However, lipid, lipoprotein and protein, as well as peptide preparations, have been claimed to have the properties of the hypothetical substance. Slusher & Roberts (1954) reported the concentration of a lipoprotein and a lipid from cow posterior hypothalamus that caused eosinopenia and depletion of adrenal ascorbic acid in intact rats. Tests in normal animals are of dubious value. Roberts (1955) added that these fractions also showed activity in rats rendered unresponsive to stress by lesions in the hypothalamus, but a paper describing this work has not yet appeared.
Recently, Porter & Rumsfeld (1956) reported that plasma-protein fractions prepared from 'hypophyseal portal-vessel blood'caused significant falls in the adrenal ascorbic acid of intact rats treated with hydrocortisone, whereas similar fractions from systemic blood were inactive.
Because only about 0-5 jmg. of our peptide material is active in our test, perhaps these lipoprotein and protein fractions, which were administered in relatively large doses, contained some adsorbed CRF, accounting for their activity.
Other authors (e.g. Martini & Morpurgo, 1955) suggested that oxytocin and vasopressin themselves were able to stimulate the release of ACTH and other hormones from the adenohypophysis. However, evidence from our Laboratory (Saffran et al. 1955; Schally & Saffran, 1956) and from Guillemin's laboratory (Guillemin & Rosenberg, 1955; Guillemin, Hearn, Cheek & Housholder, 1957) pointed to the presence in commercial preparations of vasopressin of another peptide component which stimulated the release of ACTH by adenohypophysial tissue in vitro. This paper shows the active material to be chemically related to the other hormones of the hypothalamus-neurohypophysis system, vasopressin and oxytocin. 
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That CRF is distinct from oxytocin and vasopressin was first shown in early experiments in which the activity was separated from vasopressin by paper chromatography in one system (Saffran et al. 1955 ). The present work utilizes the high resolving power of four successive chromatographic systems to isolate CRF. As depicted in Table 4 , chromatography in butanol-acetic acid separates CRF (R., 0.05-0 2) from oxytocin (Rp 0.37) as well as from a large number of small peptides (high RB) and of very basic peptides (R1 < 0 05). This system was used previously by Benfey (1953) for the separation of vasopressin and oxytocin. The mcresol system separates CRF (Rp 0.46-0.64) from ox and hog vasopressins (R1 0.85) and from occorticotrophin (RF approx. 1.0). A further separation of CRF from these hormones is brought about by the acetone-water step. This separation, as well as the chemical analysis, ensures that the final product is neither vasopressin nor oxytocin. The final, propanol-water, step resolves the active material into two or more equally-potent spots, whose relationship will be the subject of further investigation. The sequence in which the solvent systems are used is critical, because the last two systems are more sensitive to overloading and to the presence of gummy contaminants in Protopituitrin. The final product is relatively unstable, but insufficient quantities were available to attempt systematically to stabilize it, although precautions were taken to avoid contamination with heavy metals or contact with peroxides in the solvents.
The material prepared by Guillemin et al. (1957) from hypothalamic and neurohypophysial extracts, and called by them fraction D, resembles in its properties the CRF prepared in our Laboratory. Fraction D is chromatographically distinct from vasopressin, promotes the release of ACTH from isolated anterior-lobe tissue, is most unstable in the purified form (fraction AD), and is apparently a small peptide. According to Guillemin et al. (1957) fraction D may also be obtained, although by more drastic extraction procedures, from extra-neural sources as well. Fraction D exerts activity at doses ranging upward. from 0 5 ,tg., whereas our most highly purified material has detectable activity, when freshly prepared, at 1/1000 of that dose. Probably variations in assay procedures, as well as a different degree of purification, contribute to the difference in the minimal effective dose.
Lysine vasopressin and CRF have seven or eight amino acids in common; in addition, the CRF preparations consistently contain major amounts of serine and histidine, and alanine and arginine are found in smaller, variable proportions. This indicates that the CRF preparation is not yet chemically pure, although it is possible that a family of similarly active peptides may exist. The composition and specificity of CRF from various species will have to be studied in view of the differences between hog and ox vasopressin (Van Dyke, Adamsons & Engel, 1955) . Guillemin et al. (1957) have discussed the physiological significance of CRF, whose biological activity has thus far been demonstrated in a test in vitro on isolated tissues. SUMMARY 1. Neurohypophysial and hypothalamic extracts contain a corticotrophin-releasing factor (CRF) that stimulates the release of adrenocorticotrophic hormone (ACTH) from isolated anterior-pituitary tissue.
2. Serial paper chromatography in four different solvent systems has been applied to the concentration of the CRF in Protopituitrin, a posteriorpituitary concentrate prepared as a stage in the purification of oxytocin and vasopressin.
3. Purified CRF of neurohypophysial origin significantly increases the release of ACTH at doses as low as 1 ,mg.
4. Purified CRF has the chemical and chromatographic properties of a peptide, distinct from oxytocin and vasopressin.
5. After acid hydrolysis of purified CRF, the following amino acids were detected: cystine, aspartic acid, glutamic acid, glycine, proline, lysine, phenylalanine, alanine, serine and histidine.
